Alto Neuroscience (Alto Neuroscience) EV-to-Revenue : (As of May. 26, 2024)

Alto Neuroscience EV-to-Revenue Chart

Competitive Comparison of Alto Neuroscience's EV-to-Revenue

For the Biotechnology subindustry, Alto Neuroscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alto Neuroscience's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's EV-to-Revenue falls into.

Alto Neuroscience EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alto Neuroscience's EV-to-Revenue for today is calculated as:

Alto Neuroscience's current Enterprise Value is $151.46 Mil.
Alto Neuroscience's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience  (NYSE:ANRO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alto Neuroscience's PS Ratiofor today is calculated as:

Alto Neuroscience's share price for today is $12.92.
Alto Neuroscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description